Full profile

Also known asCrocus sativus, affron, Safr'Inside
Best forStress resilience on high-pressure days · Mood and emotional balance · Restful sleep and indirect next-day clarity
Evidence gradeGrade C — Limited — early or small human trials
Studied dose range28 mg/day of a standardized extract (28 mg once or 14 mg twice daily), e.g. affron at ≥3.5% Lepticrosalides.
Time to effectCumulative — mood/stress effects emerge around 2 weeks and are clearer by 4–6 weeks.
Best formBranded standardized extracts such as affron (Pharmactive) or Safr'Inside (Activ'Inside).
Food sourcesCulinary saffron (far below the 28 mg standardized dose)

Evidence, honestly graded

Double-blind RCTs support mood, stress, and sleep at 28 mg/day affron (Lopresti 2021) and meta-analyses find saffron comparable to some antidepressants with fewer adverse events, but direct healthy-adult cognition data are thin and mostly extrapolated from clinical populations. Mood evidence is roughly B; the cognition grade is honestly C.

See the full grading rubric — study type, replication, population match, and dose adequacy — in The Evidence Standard.

Side effects

  • Generally well tolerated at 28 mg
  • Occasional mild GI upset, headache, or drowsiness

Who should avoid it or check first

  • Pregnant or breastfeeding (uterine stimulant at high dose)
  • Bipolar disorder without review

Interactions

  • May add to the effects of serotonergic antidepressants (SSRIs/SNRIs/MAOIs) — use caution and discuss with a clinician

Stacks well with

  • Citicoline
  • L-Theanine
  • Rhodiola Rosea

Use caution stacking with

  • High-dose pairing with prescription serotonergic drugs without clinician guidance

What to look for on a label

  • Frame as mood and stress resilience, not focus or memory — that matches the licensed claim space in Canada.
  • Specify the branded form and marker (e.g. "affron, standardized ≥3.5% Lepticrosalides, 28 mg").

References

  • Lopresti 2021, Sleep Medicine — affron RCT. Evening affron (28 mg) improved sleep quality and morning cortisol/melatonin in adults with poor sleep. PMID 34438361; doi:10.1016/j.sleep.2021.08.001. Educational, not a product claim.
  • Hausenblas 2013, J Integrative Medicine — meta-analysis. Saffron improved depression scores vs placebo across RCTs in clinical populations. PMID 24299602; doi:10.3736/jintegrmed2013056. Educational, not a product claim.

Grades and studied doses are our conservative reading of the human research, shown for education. They are not product claims, and a studied dose is not a recommended dose.

See how Saffron compares on grade, dose, and goal in the Evidence Explorer.